Results 1 to 10 of about 39,720 (193)
The Lancet Global Health, 2022 Summary: Background: Estimates suggest that at least 30 000 children develop multidrug-resistant or rifampicin-resistant tuberculosis each year. Despite household contact management (HCM) being widely recommended, it is rarely done.
Peter J Dodd, ProfPhD +3 more
doaj +1 more source
SAGE Open Medicine, 2021 Objective: Multidrug-resistant Mycobacterium tuberculosis is a public health threat in resource-limited countries where it is easily disseminated and difficult to control.
Degineh Belachew Andarge +3 more
doaj +1 more source
Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: Comparisons of CT findings. [PDF]
PLoS ONE, 2017 Multidrug-resistant tuberculosis has emerged as a global threat. The aim of this work was to compare the CT findings of primary multidrug-resistant tuberculosis and drug-sensitive tuberculosis in non-AIDS adults.From January 2012 to February 2016, 89 ...
Duo Li, Wei He, Budong Chen, Pingxin Lv
doaj +1 more source
Journal of Medical Case Reports, 2022 Background Human immunodeficiency virus/tuberculosis coinfections have amplified the multidrug-resistant tuberculosis pandemic in many countries in Sub-Saharan Africa, and multidrug-resistant tuberculosis has become a major public health threat. There is
Lydia Nakiyingi +6 more
doaj +1 more source
Data in Brief, 2020 This set of data presents a survey data describing multidrug-resistant tuberculosis, tuberculosis patients characteristics and stress resilience during COVID-19 pandemic in West Sumatera Province, Indonesia.
Ricvan Dana Nindrea +7 more
doaj +1 more source
Periodontology 2000, EarlyView., 2023 Abstract This narrative review celebrates Europe's contribution to the current knowledge on systemically administered antimicrobials in periodontal treatment. Periodontitis is the most frequent chronic noncommunicable human disease. It is caused by dysbiotic bacterial biofilms and is commonly treated with subgingival instrumentation.
David Herrera +4 more
wiley +1 more source
PLoS ONE, 2022 BackgroundThe rate of multidrug-resistant tuberculosis is increasing at an alarming rate throughout the world. It is becoming an emerging public health problem in East Africa.
Kindu Alem Molla +2 more
doaj +1 more source
Multidrug-resistant tuberculosis in middle ear: A case report
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2023 Background: Tuberculosis (TB) continues to be a common disease in developing countries, among which middle ear TB is rare. Furthermore, it is relatively difficult to make an early diagnosis and provide follow-up treatment for middle ear TB.
Tanze Cao +5 more
doaj +1 more source
SHORT-TERM CHEMOTHERAPY REGIMEN OF MULTIDRUG-RESISTANT TUBERCULOSIS IN THE KYRGYZ REPUBLIC
Паёми Сино, 2018 Objective: To study the clinical course of tuberculosis (TB) with multiple drug resistance (MDR) in the treatment of short-term courses recommended by the WHO.
E.V. ZHDANOVA, G.K. TURDUMAMBETOVA
doaj +1 more source
International Journal of Infectious Diseases, 2022 Purpose: Multidrug-resistant tuberculosis continues to cause a public health crisis and remains a threat to health security. Drug resistance to anti-tuberculosis drugs remains a major public health problem that compromises the successes in the fight ...
P.K. Yanogo, A.L. Papique, N. Meda
doaj +1 more source